These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14413839)

  • 21. Therapeutic spectrum of uracil-mustard, a new oral antitumor drug. With special reference to the effects of small dosage in lymphomas, chronic leukemias, and ovarian carcinoma.
    SHANBROM E; MILLER S; HAAR H; OPFELL R
    JAMA; 1960 Nov; 174():1702-5. PubMed ID: 13750663
    [No Abstract]   [Full Text] [Related]  

  • 22. CLINICAL EVALUATION OF URACIL MUSTARD.
    WILLIAMS HM
    Cancer Chemother Rep; 1963 Oct; 32():73-6. PubMed ID: 14088838
    [No Abstract]   [Full Text] [Related]  

  • 23. [The action of 5-bis(2-chiorethyl)aminouracil on the blood and normal hemolymphopoietic tissues].
    SCALTRINI GC; CONIGLIARO S
    Tumori; 1961; 47():245-60. PubMed ID: 13747037
    [No Abstract]   [Full Text] [Related]  

  • 24. [A severe case of lymphographylomatosis successfully treated with dopan].
    POSLAVSKII EV; LEKSIKOV IM
    Probl Gematol Pereliv Krovi; 1959 Dec; 4():45-6. PubMed ID: 14434366
    [No Abstract]   [Full Text] [Related]  

  • 25. EFFECTS OF URACIL MUSTARD ON IN VIVO INCORPORATION OF PRECURSORS INTO NUCLEIC ACIDS OF THE WALKER TUMOR.
    SMITH SJ; BUSCH H
    Tex Rep Biol Med; 1964; 22():731-40. PubMed ID: 14226996
    [No Abstract]   [Full Text] [Related]  

  • 26. [New method of treating patients with rheumatoid arthritis using electrophoresis of the immunosuppressive preparation dopan from a dimexide solution].
    Kozlova LA; Tereshina LG
    Vopr Kurortol Fizioter Lech Fiz Kult; 1986; (1):33-5. PubMed ID: 3518232
    [No Abstract]   [Full Text] [Related]  

  • 27. [Research on the possibilities of inducing antigenic changes in tumor cells by treatment "in vivo" with chemotherapeutic agents].
    Melan F; Nicolin A; Testorelli C
    Arch Ital Patol Clin Tumori; 1968; 11(1):203-13. PubMed ID: 5745128
    [No Abstract]   [Full Text] [Related]  

  • 28. [USE OF DIMEZOL-14 IN PROTECTING ACT. AUREOFACIENS MYCELIA FROM THE ACTION OF TYPE I ACTINOPHAGE].
    GOLDFARB DM; BORISOVA LN
    Antibiotiki; 1963 Dec; 8():1071-4. PubMed ID: 14172760
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experimental study of antitumor action of rubomycin in combination with some cytostatic compounds].
    Rossolimo OK; Lepeshkina GN
    Antibiotiki; 1967 Mar; 12(3):206-12. PubMed ID: 4969789
    [No Abstract]   [Full Text] [Related]  

  • 30. [REDUCING THE TOXICITY OF DOPAN BY MEANS OF AMINOETHYL-ISOTHIURONIUM (AET) IN EXPERIMENTS ON MONKEYS].
    SPASSKAIA IG; PLATONOVA GN; SOLOPAEVA IM; SEMENOV LF; ZEITUNIAN KA; LARIONOV LF
    Vopr Onkol; 1963; 9():44-6. PubMed ID: 14148614
    [No Abstract]   [Full Text] [Related]  

  • 31. [A CASE OF ACUTE POISONING WITH DOPAN].
    BOGORODSKAIA TA; MIKHAILOVA EN; OGIBINA LN; SHCHERBA MM
    Ter Arkh; 1965 Jan; 37():107-9. PubMed ID: 14342983
    [No Abstract]   [Full Text] [Related]  

  • 32. THERAPEUTIC EFFECT OF ANTICANCER DRUGS ON SKIN CANCER.
    HIGUCHI K; UEMATSU K
    Kyushu J Med Sci; 1963 Oct; 14():203-9. PubMed ID: 14104458
    [No Abstract]   [Full Text] [Related]  

  • 33. [CHEMOTHERAPY OF UTERINE CERVIX CARCINOMA].
    PERITI P; MAIJNELLI M
    Riv Ostet Ginecol; 1964 Jan; 19():56-60. PubMed ID: 14165768
    [No Abstract]   [Full Text] [Related]  

  • 34. A clinical study of 5-fluorouracil.
    GOLD GL; HALL TC; SHNIDER BJ; SELAWRY O; COLSKY J; OWENS AH; DEDERICK MM; HOLLAND JF; BRINDLEY CO; JONES R
    Cancer Res; 1959 Oct; 19():935-9. PubMed ID: 13850554
    [No Abstract]   [Full Text] [Related]  

  • 35. A synopsis of recent investigations of 6-azauridine (NSC-32074).
    WELCH AD; HANDSCHUMACHER RE; FINCH SC; JAFFE JJ; CARDOSO SS; CALABRESI P
    Cancer Chemother Rep; 1960 Nov; 9():39-46. PubMed ID: 13784172
    [No Abstract]   [Full Text] [Related]  

  • 36. 5-Fluorouracil and its ribosides.
    WHITE FR
    Cancer Chemother Rep; 1960 Feb; 6():94-114. PubMed ID: 13844347
    [No Abstract]   [Full Text] [Related]  

  • 37. Potentiation of 5-fluorouracil by combination chemotherapy in animals.
    WOLBERG WH; CURRERI AR
    Cancer Chemother Rep; 1960 Feb; 6():6-7. PubMed ID: 13845611
    [No Abstract]   [Full Text] [Related]  

  • 38. Uracil mustard revisited.
    Kennedy BJ; Torkelson JL; Torlakovic E
    Cancer; 1999 May; 85(10):2265-72. PubMed ID: 10326707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Research on the antimitotic properties of antagonists of natural pyrimidine bases. I. 5-Fluorouracil and related compounds].
    DEYSSON G; TRUHAUT R
    Bull Soc Chim Biol (Paris); 1962; 44():513-24. PubMed ID: 13885944
    [No Abstract]   [Full Text] [Related]  

  • 40. [EXPERIMENTAL AND CLINICAL FINDINGS ON THE THERAPEUTIC USE OF A NEW ALKYLATING DRUG: URACIL MUSTARD].
    BALLERINI G; CASTOLDI G; RICCI N; TENZE L
    Clin Ter; 1965 Jan; 32():49-61. PubMed ID: 14262587
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.